Urinary Tissue Inhibitor of Metalloproteinases-2 and Insulin-Like Growth Factor–Binding Protein 7 Do Not Correlate With Disease Severity in ADPKD Patients
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by progressive cyst formation and variable renal function decline that frequently leads to end-stage renal failure. With the advent of renoprotective treatment, there is renewed interest in noninvasive biomarkers to...
Main Authors: | Shosha E.I. Dekker, L. Renee Ruhaak, Fred P.H.T.M. Romijn, Esther Meijer, Christa M. Cobbaert, Johan W. de Fijter, Darius Soonawala, Joost P.H. Drenth, Ron T. Gansevoort, Dorien J.M. Peters, Jack F. Wetzels, Robert Zietse |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2019-06-01
|
Series: | Kidney International Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2468024919301160 |
Similar Items
-
Urinary metabolites associate with the rate of kidney function decline in patients with autosomal dominant polycystic kidney disease.
by: Shosha E I Dekker, et al.
Published: (2020-01-01) -
The predictive value of TIMP-2 and IGFBP7 for kidney failure and 30-day mortality after elective cardiac surgery
by: Kevin Esmeijer, et al.
Published: (2021-01-01) -
Author’s Reply to Correspondence: “Effect of Tolvaptan Treatment on Acid−Base Homeostasis in ADPKD Patients”
by: Judith E. Heida, et al.
Published: (2021-06-01) -
Transplanting the Elderly: Mandatory Age- and Minimal Histocompatibility Matching
by: Geertje J. Dreyer, et al.
Published: (2020-03-01) -
Intrafamilial Variability of ADPKD
by: Matthew B. Lanktree, et al.
Published: (2019-07-01)